产品分类
联系我们
电话: 0519-85788828
传真: 0519-89960117
手机: 13775037613
E-mail: sales@chemrenpharm.com
地址: 江苏省常州市新北区百丈工业园
QQ:
2500035664
产品详细: |
Description of:AV-951(Tivozanib)
AV-951 (Tivozanib) is a novel quinoline-urea derivative and now developed by AVEO. AV-951 also inhibits phosphorylation of PDGFRß and c-Kit with IC50 of 1.72nm and 1.63nM, AV-951 (Tivozanib) will block VEGF-dependent activation of mitogen-activated protein kinases and proliferation of endothelial cells. In vivo studies show that AV-951 also decreases the micro vessel density and suppresses VEGFR-2 phosphorylation levels in tumor xenografts, especially at a concentration of 1mg/kg (p.o. administration). AV-951 (Tivozanib) shows almost complete inhibition of tumor xenografts growth (TGI>85%) in athymic rats. Theoretical analysis:AV-951(Tivozanib) M.Wt: 454.86 Formula: C22H19ClN4O5 Solubility: DMSO Purity: >99% Storage: at -20℃ 2 years CAS No: 475108-18-0 Availability and price:AV-951(Tivozanib) Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g Stock : in stock We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
相关产品 : |
|
|
|
|
||||||||
|
|
|
|